Form D · Other Technology
Shuttle Pharmaceuticals Holdings, Inc.
Gaithersburg, MD · CIK 0001757499
Offering snapshot reported May 15, 2026 · SEC filing
- Reported sold
- $9.96M Offering amount: $9.96M
- Investors reported
- 47 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 30, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 15, 2026 | Initial | $9,955,000 | No comparison | 47 | SEC filing |
| Nov 7, 2025 | Initial | $2,499,998 | No comparison | 1 | SEC filing |
| Jun 26, 2025 | Initial | $4,250,000 | No comparison | 1 | SEC filing |
| Oct 25, 2024 | Initial | $790,000 | No comparison | 5 | SEC filing |
| Jan 20, 2023 | Initial | $4,000,000 | No comparison | 1 | SEC filing |
| Aug 15, 2022 | Initial | $125,000 | No comparison | 3 | SEC filing |
| Feb 22, 2022 | Initial | $365,000 | No comparison | 11 | SEC filing |
| Jan 4, 2022 | Initial | $500,000 | No comparison | 2 | SEC filing |
| Jan 31, 2019 | Initial | $912,500 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $1.03M
- Finders' fees
- $0
- Form D file number
- 021-584298
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| E.F. Hutton & Co. | 000322687 |
Source: Form D, filed May 15, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Adkins | Director |
| Milton Brown | Director |
| Adam Chambers | Director |
| Christopher Cooper | Director, Executive |
| Peter Dritschillo | Executive |
| Peter Dritschilo | Executive |
| Anatoly Dritschilo | Director, Executive |
| Amir Heshmatpour | Director |
| Bette Jacobs | Director |
| Mira Jung | Executive |
| Yuying Liang | Executive |
| Angel Liriano | Director |
| Timothy Lorber | Executive |
| Oleh Nabyt | Director |
| Sachin Pathigoda | Director |
| Tyvin Rich | Executive |
| Steven Richards | Director |
| Joshua Schafer | Director |
| Josh Schafer | Director |
| George Scorcis | Director |
| George Scorsis | Director |
| Chris Senanayake | Director |
| Ryan Trasolini | Executive |
| Joseph Tung | Director |
| Michael Vander Hoek | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
401 Professional Drive Suite 260
Gaithersburg, MD, 20879
Phone: (240) 403-4212
Gaithersburg, MD, 20879
Phone: (240) 403-4212